NYSEArca - Nasdaq Real Time Price USD

Invesco Biotechnology & Genome ETF (PBE)

64.76 -0.25 (-0.38%)
As of 1:10 PM EDT. Market Open.
Loading Chart for PBE
DELL
  • Previous Close 65.01
  • Open 64.95
  • Bid 64.74 x 1100
  • Ask 64.79 x 1300
  • Day's Range 64.49 - 64.76
  • 52 Week Range 52.47 - 67.76
  • Volume 3,184
  • Avg. Volume 15,032
  • Net Assets 245.81M
  • NAV 64.98
  • PE Ratio (TTM) 17.17
  • Yield 0.06%
  • YTD Daily Total Return -1.22%
  • Beta (5Y Monthly) 0.83
  • Expense Ratio (net) 0.58%

The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Invesco

Fund Family

Health

Fund Category

245.81M

Net Assets

2005-06-23

Inception Date

Performance Overview: PBE

Trailing returns as of 5/16/2024. Category is Health.

YTD Return

PBE
1.22%
Category
0.45%
 

1-Year Return

PBE
5.25%
Category
1.63%
 

3-Year Return

PBE
2.91%
Category
3.64%
 

People Also Watch

Holdings: PBE

Top 10 Holdings (46.66% of Total Assets)

SymbolCompany% Assets
NBIX
NBIX 5.45%
BIIB
BIIB 5.15%
AMGN
AMGN 5.08%
REGN
REGN 4.95%
VRTX
VRTX 4.91%
BMRN
BMRN 4.79%
GILD
GILD 4.76%
TECH
TECH 4.72%
PTCT
PTCT 3.55%
COLL
COLL 3.30%

Sector Weightings

SectorPBE
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: PBE

Research Reports: PBE

Related Tickers